脑部放疗，上午比下午敏感许多！, r/ p6 N0 |5 [$ z/ o1 J
* B3 S4 F2 \# r2 z0 x% Q
9 B- m# I, d$ N# x* t
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
n+ f) I/ Z- r( j$ Q7 S3 dGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?0 A( n: P7 U* c3 ~/ |
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.% o9 D" ~ \; L6 G S" y
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
- U8 q" T" T, K! H" ^0 y! Z$ n! o1 _, c0 w2 ^
Abstract! \$ I( q8 j( r8 |1 Z; i
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.; C3 p% y# c6 @* O2 _# `% A
v2 @, }/ B' J0 K0 `2 I- a( c* K: `& }METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.5 w" B6 ^5 J6 w& T0 r' S
) \( u! U; N8 |
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
% W. t# b/ f; b; f
: f- C, A" ~& W" j% ~% w! mCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
, G5 D$ e0 w" G6 v2 c- f! Z
/ J5 J5 l2 w4 \# q9 F |
显身卡
